Search for Clinical Trial Results
Angioedemas, Hereditary - 67 Studies Found
Status | Study |
Completed |
Study Name: A Call Center During HAE Attacks (SOS HAE) Condition: Hereditary Angioedema Date: 2012-08-21 Interventions: Other: phone to the call center recommendations to phone to the call center for all the patients who hav |
Completed |
Study Name: A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor Condition: Hereditary Angioedema Date: 2014-09-16 Interventions:
|
Recruiting |
Study Name: C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2011-07-18 Interventions: Drug: rhC1INH or pdC1INH C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (Ru |
Completed |
Study Name: Berinert P Study of Subcutaneous Versus Intravenous Administration Condition: Hereditary Angioedema Date: 2008-09-04 Interventions: Drug: C1-Esterase Inhibitor 1000 I.E. Other Name: Be |
Completed |
Study Name: Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Condition: Hereditary Angioedema Date: 2010-01-28 Interventions: Drug: ecallantide 30 mg SC Other Name: Kalbitor |
Completed |
Study Name: Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks Condition: Hereditary Angioedema Date: 2012-06-29 Interventions: Biological: CINRYZE with rHuPH20 Other Names:
|
Completed |
Study Name: A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE Condition: Hereditary Angioedema Date: 2009-06-03 Interventions: Biological: C1 inhibitor (human) [C1 INH] Other Names:
|
Completed |
Study Name: Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE Condition: Hereditary Angioedema Date: 2011-10-13 Interventions: Drug: Icatibant 30 mg subcutaneous dose of Icatibant |
Completed |
Study Name: Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE Condition: Hereditary Angioedema Date: 2013-11-05 Interventions:
|
Completed |
Study Name: EASSI - Evaluation of the Safety of Self-Administration With Icatibant Condition: Hereditary Angioedema Date: 2009-10-16 Interventions: Drug: Icatibant Single subcutaneous injection of icatibant, 30 mg |